Copyright Reports & Markets. All rights reserved.

Global Autologous Transfusion Products Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Autologous Transfusion Products Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Intraoperative Autologous Transfusion Products
    • 1.3.3 Postoperative Autologous Transfusion Products
    • 1.3.4 Dual Mode Autologous Transfusion Products
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Autologous Transfusion Products Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Organ Transplant Surgery
    • 1.4.3 Orthopedic Surgery
    • 1.4.4 Heart Surgery
    • 1.4.5 Others
  • 1.5 Global Autologous Transfusion Products Market Size & Forecast
    • 1.5.1 Global Autologous Transfusion Products Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Autologous Transfusion Products Sales Quantity (2021-2032)
    • 1.5.3 Global Autologous Transfusion Products Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 LivaNova
    • 2.1.1 LivaNova Details
    • 2.1.2 LivaNova Major Business
    • 2.1.3 LivaNova Autologous Transfusion Products Product and Services
    • 2.1.4 LivaNova Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 LivaNova Recent Developments/Updates
  • 2.2 Haemonetics
    • 2.2.1 Haemonetics Details
    • 2.2.2 Haemonetics Major Business
    • 2.2.3 Haemonetics Autologous Transfusion Products Product and Services
    • 2.2.4 Haemonetics Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Haemonetics Recent Developments/Updates
  • 2.3 Getinge AB
    • 2.3.1 Getinge AB Details
    • 2.3.2 Getinge AB Major Business
    • 2.3.3 Getinge AB Autologous Transfusion Products Product and Services
    • 2.3.4 Getinge AB Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Getinge AB Recent Developments/Updates
  • 2.4 Medtronic
    • 2.4.1 Medtronic Details
    • 2.4.2 Medtronic Major Business
    • 2.4.3 Medtronic Autologous Transfusion Products Product and Services
    • 2.4.4 Medtronic Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Medtronic Recent Developments/Updates
  • 2.5 Terumo
    • 2.5.1 Terumo Details
    • 2.5.2 Terumo Major Business
    • 2.5.3 Terumo Autologous Transfusion Products Product and Services
    • 2.5.4 Terumo Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Terumo Recent Developments/Updates
  • 2.6 Braile Biomedica
    • 2.6.1 Braile Biomedica Details
    • 2.6.2 Braile Biomedica Major Business
    • 2.6.3 Braile Biomedica Autologous Transfusion Products Product and Services
    • 2.6.4 Braile Biomedica Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Braile Biomedica Recent Developments/Updates
  • 2.7 Fresenius Kabi
    • 2.7.1 Fresenius Kabi Details
    • 2.7.2 Fresenius Kabi Major Business
    • 2.7.3 Fresenius Kabi Autologous Transfusion Products Product and Services
    • 2.7.4 Fresenius Kabi Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Fresenius Kabi Recent Developments/Updates
  • 2.8 Appligent
    • 2.8.1 Appligent Details
    • 2.8.2 Appligent Major Business
    • 2.8.3 Appligent Autologous Transfusion Products Product and Services
    • 2.8.4 Appligent Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Appligent Recent Developments/Updates
  • 2.9 Wandong Health Sources
    • 2.9.1 Wandong Health Sources Details
    • 2.9.2 Wandong Health Sources Major Business
    • 2.9.3 Wandong Health Sources Autologous Transfusion Products Product and Services
    • 2.9.4 Wandong Health Sources Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Wandong Health Sources Recent Developments/Updates
  • 2.10 Advancis Surgical
    • 2.10.1 Advancis Surgical Details
    • 2.10.2 Advancis Surgical Major Business
    • 2.10.3 Advancis Surgical Autologous Transfusion Products Product and Services
    • 2.10.4 Advancis Surgical Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Advancis Surgical Recent Developments/Updates
  • 2.11 Macopharma SA
    • 2.11.1 Macopharma SA Details
    • 2.11.2 Macopharma SA Major Business
    • 2.11.3 Macopharma SA Autologous Transfusion Products Product and Services
    • 2.11.4 Macopharma SA Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Macopharma SA Recent Developments/Updates
  • 2.12 Asahi Kasei Medical
    • 2.12.1 Asahi Kasei Medical Details
    • 2.12.2 Asahi Kasei Medical Major Business
    • 2.12.3 Asahi Kasei Medical Autologous Transfusion Products Product and Services
    • 2.12.4 Asahi Kasei Medical Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Asahi Kasei Medical Recent Developments/Updates
  • 2.13 Stryker Corporation
    • 2.13.1 Stryker Corporation Details
    • 2.13.2 Stryker Corporation Major Business
    • 2.13.3 Stryker Corporation Autologous Transfusion Products Product and Services
    • 2.13.4 Stryker Corporation Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Stryker Corporation Recent Developments/Updates
  • 2.14 Zimmer Biomet Holdings
    • 2.14.1 Zimmer Biomet Holdings Details
    • 2.14.2 Zimmer Biomet Holdings Major Business
    • 2.14.3 Zimmer Biomet Holdings Autologous Transfusion Products Product and Services
    • 2.14.4 Zimmer Biomet Holdings Autologous Transfusion Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Zimmer Biomet Holdings Recent Developments/Updates

3 Competitive Environment: Autologous Transfusion Products by Manufacturer

  • 3.1 Global Autologous Transfusion Products Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Autologous Transfusion Products Revenue by Manufacturer (2021-2026)
  • 3.3 Global Autologous Transfusion Products Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Autologous Transfusion Products by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Autologous Transfusion Products Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Autologous Transfusion Products Manufacturer Market Share in 2025
  • 3.5 Autologous Transfusion Products Market: Overall Company Footprint Analysis
    • 3.5.1 Autologous Transfusion Products Market: Region Footprint
    • 3.5.2 Autologous Transfusion Products Market: Company Product Type Footprint
    • 3.5.3 Autologous Transfusion Products Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Autologous Transfusion Products Market Size by Region
    • 4.1.1 Global Autologous Transfusion Products Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Autologous Transfusion Products Consumption Value by Region (2021-2032)
    • 4.1.3 Global Autologous Transfusion Products Average Price by Region (2021-2032)
  • 4.2 North America Autologous Transfusion Products Consumption Value (2021-2032)
  • 4.3 Europe Autologous Transfusion Products Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Autologous Transfusion Products Consumption Value (2021-2032)
  • 4.5 South America Autologous Transfusion Products Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Autologous Transfusion Products Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Autologous Transfusion Products Sales Quantity by Type (2021-2032)
  • 5.2 Global Autologous Transfusion Products Consumption Value by Type (2021-2032)
  • 5.3 Global Autologous Transfusion Products Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Autologous Transfusion Products Sales Quantity by Application (2021-2032)
  • 6.2 Global Autologous Transfusion Products Consumption Value by Application (2021-2032)
  • 6.3 Global Autologous Transfusion Products Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Autologous Transfusion Products Sales Quantity by Type (2021-2032)
  • 7.2 North America Autologous Transfusion Products Sales Quantity by Application (2021-2032)
  • 7.3 North America Autologous Transfusion Products Market Size by Country
    • 7.3.1 North America Autologous Transfusion Products Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Autologous Transfusion Products Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Autologous Transfusion Products Sales Quantity by Type (2021-2032)
  • 8.2 Europe Autologous Transfusion Products Sales Quantity by Application (2021-2032)
  • 8.3 Europe Autologous Transfusion Products Market Size by Country
    • 8.3.1 Europe Autologous Transfusion Products Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Autologous Transfusion Products Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Autologous Transfusion Products Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Autologous Transfusion Products Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Autologous Transfusion Products Market Size by Region
    • 9.3.1 Asia-Pacific Autologous Transfusion Products Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Autologous Transfusion Products Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Autologous Transfusion Products Sales Quantity by Type (2021-2032)
  • 10.2 South America Autologous Transfusion Products Sales Quantity by Application (2021-2032)
  • 10.3 South America Autologous Transfusion Products Market Size by Country
    • 10.3.1 South America Autologous Transfusion Products Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Autologous Transfusion Products Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Autologous Transfusion Products Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Autologous Transfusion Products Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Autologous Transfusion Products Market Size by Country
    • 11.3.1 Middle East & Africa Autologous Transfusion Products Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Autologous Transfusion Products Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Autologous Transfusion Products Market Drivers
  • 12.2 Autologous Transfusion Products Market Restraints
  • 12.3 Autologous Transfusion Products Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Autologous Transfusion Products and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Autologous Transfusion Products
  • 13.3 Autologous Transfusion Products Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Autologous Transfusion Products Typical Distributors
  • 14.3 Autologous Transfusion Products Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Autologous Transfusion Products market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Autologous Transfusion Products are products that collect, process and preserve a patient"s own blood for use in situations where a patient requires transfusion during surgery or other medical procedures. Compared with traditional donor blood, autologous blood transfusion products can avoid potential risks such as infection and immune reaction transmitted by donor blood, and can also reduce problems such as shortage of donor blood and cost of donor blood.
    This report is a detailed and comprehensive analysis for global Autologous Transfusion Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Autologous Transfusion Products market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Autologous Transfusion Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Autologous Transfusion Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Autologous Transfusion Products market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Autologous Transfusion Products
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Autologous Transfusion Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LivaNova, Haemonetics, Getinge AB, Medtronic, Terumo, Braile Biomedica, Fresenius Kabi, Appligent, Wandong Health Sources, Advancis Surgical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Autologous Transfusion Products market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Intraoperative Autologous Transfusion Products
    Postoperative Autologous Transfusion Products
    Dual Mode Autologous Transfusion Products
    Market segment by Application
    Organ Transplant Surgery
    Orthopedic Surgery
    Heart Surgery
    Others
    Major players covered
    LivaNova
    Haemonetics
    Getinge AB
    Medtronic
    Terumo
    Braile Biomedica
    Fresenius Kabi
    Appligent
    Wandong Health Sources
    Advancis Surgical
    Macopharma SA
    Asahi Kasei Medical
    Stryker Corporation
    Zimmer Biomet Holdings
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Autologous Transfusion Products product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Autologous Transfusion Products, with price, sales quantity, revenue, and global market share of Autologous Transfusion Products from 2021 to 2026.
    Chapter 3, the Autologous Transfusion Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Autologous Transfusion Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Autologous Transfusion Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Autologous Transfusion Products.
    Chapter 14 and 15, to describe Autologous Transfusion Products sales channel, distributors, customers, research findings and conclusion.

    Buy now